Total Payments
$63,236
2024 Payments
$2,807
Companies
18
Transactions
164
Medicare Patients
949
Medicare Billing
$106,908
Payment Breakdown by Category
Other$27,713 (43.8%)
Consulting$23,450 (37.1%)
Food & Beverage$6,268 (9.9%)
Travel$5,421 (8.6%)
Education$372.93 (0.6%)
Gifts$11.49 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,213 | 13 | 38.3% |
| Consulting Fee | $23,450 | 7 | 37.1% |
| Food and Beverage | $6,268 | 119 | 9.9% |
| Travel and Lodging | $5,421 | 19 | 8.6% |
| Honoraria | $3,500 | 1 | 5.5% |
| Education | $372.93 | 4 | 0.6% |
| Gift | $11.49 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $17,626 | 44 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $13,082 | 23 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $11,924 | 5 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $8,932 | 18 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $5,300 | 10 | $0 (2023) |
| Janssen Biotech, Inc. | $3,100 | 20 | $0 (2024) |
| Celgene Corporation | $1,854 | 18 | $0 (2024) |
| Mallinckrodt LLC | $325.37 | 7 | $0 (2017) |
| BOSTON SCIENTIFIC CORPORATION | $280.34 | 3 | $0 (2017) |
| Olympus America Inc. | $254.42 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,807 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($2,177) |
| 2023 | $10,380 | 36 | Pharmacosmos Therapeutics Inc. ($5,300) |
| 2022 | $7,647 | 18 | E.R. Squibb & Sons, L.L.C. ($6,056) |
| 2021 | $6,085 | 9 | E.R. Squibb & Sons, L.L.C. ($5,750) |
| 2020 | $8,721 | 14 | Janssen Scientific Affairs, LLC ($7,910) |
| 2019 | $18,701 | 30 | AbbVie, Inc. ($13,396) |
| 2018 | $7,624 | 26 | Takeda Pharmaceuticals U.S.A., Inc. ($6,598) |
| 2017 | $1,271 | 17 | Mallinckrodt LLC ($325.37) |
All Payment Transactions
164 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 10/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $37.38 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Immunology | ||||||
| 10/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $46.71 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $74.99 | General |
| Category: Immunology | ||||||
| 06/28/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $109.88 | General |
| Category: Neuroscience | ||||||
| 06/27/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/20/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $108.00 | General |
| Category: Neuroscience | ||||||
| 02/07/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $129.62 | General |
| Category: Neuroscience | ||||||
| 01/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $33.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/10/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $2.32 | General |
| Category: Neuroscience | ||||||
| 12/14/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $140.69 | General |
| Category: Immunology | ||||||
| 12/14/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $81.30 | General |
| Category: Neuroscience | ||||||
| 11/30/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $122.01 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/27/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Consulting Fee | Cash or cash equivalent | $2,085.00 | General |
| Category: Immunology | ||||||
| 09/12/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $29.95 | General |
| Category: Neuroscience | ||||||
| 08/29/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/31/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.35 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 171 | 177 | $68,991 | $20,563 |
| 2022 | 8 | 199 | 209 | $82,120 | $22,205 |
| 2021 | 10 | 309 | 330 | $117,513 | $33,791 |
| 2020 | 10 | 270 | 312 | $111,655 | $30,347 |
Total Patients
949
Total Services
1,028
Medicare Billing
$106,908
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 65 | 66 | $30,844 | $8,238 | 26.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 18 | 19 | $11,228 | $4,057 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 25 | $7,505 | $2,283 | 30.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $6,192 | $2,051 | 33.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $6,125 | $1,706 | 27.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $4,281 | $1,326 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $2,816 | $901.23 | 32.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 63 | 63 | $29,682 | $6,610 | 22.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 26 | 26 | $15,496 | $5,235 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 42 | $12,758 | $3,925 | 30.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 29 | 30 | $10,112 | $2,795 | 27.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $5,100 | $1,490 | 29.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $3,760 | $1,313 | 34.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $3,414 | $778.73 | 22.8% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 12 | 13 | $1,798 | $59.23 | 3.3% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 63 | 63 | $30,252 | $6,711 | 22.2% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 31 | 31 | $18,908 | $6,411 | 33.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 54 | $14,694 | $5,693 | 38.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 43 | 44 | $14,566 | $3,931 | 27.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 28 | $9,045 | $3,129 | 34.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 19 | 19 | $9,387 | $2,871 | 30.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 16 | $5,920 | $2,417 | 40.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $5,247 | $1,645 | 31.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 13 | $2,405 | $760.98 | 31.6% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2021 | 51 | 51 | $7,089 | $223.93 | 3.2% |
About Dr. Sean Fine, M.D
Dr. Sean Fine, M.D is a Gastroenterology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2011. The National Provider Identifier (NPI) number assigned to this provider is 1114210267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sean Fine, M.D has received a total of $63,236 in payments from pharmaceutical and medical device companies, with $2,807 received in 2024. These payments were reported across 164 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,213).
As a Medicare-enrolled provider, Fine has provided services to 949 Medicare beneficiaries, totaling 1,028 services with total Medicare billing of $106,908. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Providence, RI
- Active Since 05/24/2011
- Last Updated 11/25/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1114210267
Products in Payments
- STELARA (Biological) $15,753
- ZEPOSIA (Drug) $7,535
- Entyvio (Biological) $6,620
- Humira (Biological) $6,397
- MONOFERRIC (Drug) $5,300
- ENTYVIO (Biological) $2,312
- SKYRIZI (Biological) $1,910
- RINVOQ (Biological) $575.00
- TREMFYA (Drug) $429.46
- OFIRMEV (Drug) $325.37
- OTHER- BSC PRODUCT NOT LISTED (Device) $169.58
- TECENTRIQ (Biological) $123.25
- ELEVIEW (Device) $113.22
- WALLFLEX (Device) $110.76
- EndoCapsule (Device) $106.24
- Olympus EMR & ESD Devices (Device) $96.38
- APRISO (Drug) $88.11
- PillCam (Device) $81.80
- Ozanimod (Drug) $69.39
- VIBERZI (Drug) $58.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Providence
Thomas Sepe, Md, MD
Gastroenterology — Payments: $383,523
Gastroenterology $383,523
Paul Akerman, Md, MD
Gastroenterology — Payments: $163,964
Gastroenterology $163,964
Dr. Alan Epstein, M.d, M.D
Gastroenterology — Payments: $59,290
Gastroenterology $59,290
Samir Shah, M.d, M.D
Gastroenterology — Payments: $45,756
Gastroenterology $45,756
Lisa Mueller, Md, MD
Gastroenterology — Payments: $22,692
Gastroenterology $22,692
Eric Newton, Md, MD
Gastroenterology — Payments: $20,736
Gastroenterology $20,736